Literature DB >> 32776162

Current perspectives on the dysregulated microRNAs in gastric cancer.

Shirin Azarbarzin1, Reza Safaralizadeh2, Mahdi Banan Khojasteh1, Amir Baghbanzadeh3, Behzad Baradaran4.   

Abstract

Since gastric cancer (GC) is diagnosed at advanced stages, the survival rate is low in affected people. In this regard, investigating the mechanisms underlying GC development, are so critical. MiRNAs, which are small non coding RNAs, as a post transcriptional repressor, regulate expression of target genes by stimulating breakage or transcription suppression of their targets therefore aberrant expression of miRNAs leading to GC carcinogenesis. In the last decades, there have been various studies approving the pivotal role of miRNAs in various phases of GC development including cancer initiation, proliferation, migration, invasion, metastasis, angiogenesis, apoptosis, and drug resistance. Therefore, the present review aimed at summarizing the dysregulated miRNAs which contribute to various cellular and developmental mechanisms such as, proliferation, apoptosis, invasion, migration, and angiogenesis. Moreover, it provides an overview on novel miRNAs involved in drug resistance and circular miRNAs as cancer biomarkers. Thereafter, it is hoped that the present study will shed more light on diagnostic and prognostic biomarkers of GC, and potential GC treatments based on miRNAs.

Entities:  

Keywords:  Angiogenesis; Gastric cancer; Invasion; Migration; Proliferation; miRNAs

Mesh:

Substances:

Year:  2020        PMID: 32776162     DOI: 10.1007/s11033-020-05720-z

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  71 in total

1.  The Value of MiR-383, an Intronic MiRNA, as a Diagnostic and Prognostic Biomarker in Intestinal-Type Gastric Cancer.

Authors:  Shirin Azarbarzin; Mohammad Ali Hosseinpour Feizi; Reza Safaralizadeh; Mina Kazemzadeh; Alavieh Fateh
Journal:  Biochem Genet       Date:  2017-02-27       Impact factor: 1.890

2.  MicroRNA-193a and taxol combination: A new strategy for treatment of colorectal cancer.

Authors:  Maryam Hejazi; Elham Baghbani; Mohammad Amini; Tayebeh Rezaei; Ayuob Aghanejad; Jafar Mosafer; Ahad Mokhtarzadeh; Behzad Baradaran
Journal:  J Cell Biochem       Date:  2019-09-12       Impact factor: 4.429

Review 3.  The Japanese Viewpoint on the Histopathology of Early Gastric Cancer.

Authors:  Shigeki Sekine; Hiroshi Yoshida; Marnix Jansen; Ryoji Kushima
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

Review 4.  MicroRNAs in cancer.

Authors:  Yong Sun Lee; Anindya Dutta
Journal:  Annu Rev Pathol       Date:  2009       Impact factor: 23.472

5.  Acute preload effects of furosemide.

Authors:  P A Kraus; J Lipman; P J Becker
Journal:  Chest       Date:  1990-07       Impact factor: 9.410

6.  The Value of miR-299-5p in Diagnosis and Prognosis of Intestinal-Type Gastric Adenocarcinoma.

Authors:  Shirin Azarbarzin; Mohammad Ali Hosseinpour Feizi; Reza Safaralizadeh; Reyhaneh Ravanbakhsh; Mina Kazemzadeh; Alavieh Fateh; Nasibeh Karimi; Yaghoub Moaddab
Journal:  Biochem Genet       Date:  2016-03-23       Impact factor: 1.890

7.  MicroRNA (miRNA) in cancer.

Authors:  Kaladhar B Reddy
Journal:  Cancer Cell Int       Date:  2015-04-02       Impact factor: 5.722

Review 8.  Gastric Cancer Screening by Combined Determination of Serum Helicobacter pylori Antibody and Pepsinogen Concentrations: ABC Method for Gastric Cancer Screening.

Authors:  Xian-Zhe Chen; Cheng-Zhi Huang; Wei-Xian Hu; Ying Liu; Xue-Qing Yao
Journal:  Chin Med J (Engl)       Date:  2018-05-20       Impact factor: 2.628

9.  A high-throughput 3' UTR reporter screening identifies microRNA interactomes of cancer genes.

Authors:  Gert Van Peer; Evelien Mets; Shana Claeys; Ines De Punt; Steve Lefever; Maté Ongenaert; Pieter Rondou; Frank Speleman; Pieter Mestdagh; Jo Vandesompele
Journal:  PLoS One       Date:  2018-03-09       Impact factor: 3.240

Review 10.  Recent advances in gastric cancer early diagnosis.

Authors:  Laura Necula; Lilia Matei; Denisa Dragu; Ana I Neagu; Cristina Mambet; Saviana Nedeianu; Coralia Bleotu; Carmen C Diaconu; Mihaela Chivu-Economescu
Journal:  World J Gastroenterol       Date:  2019-05-07       Impact factor: 5.742

View more
  1 in total

1.  Knockdown circZNF131 Inhibits Cell Progression and Glycolysis in Gastric Cancer Through miR-186-5p/PFKFB2 Axis.

Authors:  Xingjie Shen; Xiaoyan Zhu; Peixin Hu; Tingting Ji; Ying Qin; Jingyu Zhu
Journal:  Biochem Genet       Date:  2022-01-21       Impact factor: 2.220

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.